Khem Wood, in Braggs, OK - Dentist

Khem Wood, is a Dentist - General Practice based in Braggs, Oklahoma. Khem Wood is licensed to practice in Oklahoma (license number 4536) and his current practice location is Camp Gruber 100 Highway 10, Braggs, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (626) 392-8649.

NPI number for Khem Wood is 1063429116 and his current mailing address is Po Box 457, Miami, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1063429116.

Contact Information

	Khem Wood,
	Camp Gruber 100 Highway 10, Braggs, OK 74423
	(626) 392-8649
	Not Available

Healthcare Provider's Profile

Full Name	Khem Wood
Gender	Male
Speciality	Dentist - General Practice
Location	Camp Gruber 100 Highway 10, Braggs, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1063429116
Provider Enumeration Date: 08/02/2006
Last Update Date: 02/29/2016

Medical Identifiers

Medical identifiers for Khem Wood such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063429116	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1223G0001X	Dentist - General Practice	4536 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Khem Wood is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Khem Wood, Po Box 457, Miami, OK 74355-0457 Ph: () -	Khem Wood, Camp Gruber 100 Highway 10, Braggs, OK 74423 Ph: (626) 392-8649

News Archive

Interim data from long-term extension Tecfidera® (dimethyl fumarate) study

Biogen (NASDAQ: BIIB) will, this week, present data at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona, Spain, demonstrating the efficacy and safety of TECFIDERA® (dimethyl fumarate) across a broad range of people with relapsing-remitting multiple sclerosis (RRMS).

Chembio Diagnostics to supply over 2000 PrimaTB STAT-PAK tuberculosis testing kits

Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, has agreed to provide over 2,000 PrimaTB STAT-PAK tuberculosis (TB) testing kits which are approved for use in Macaques to the Orangutan Conservancy (OC) to support the organization's continued drive to raise the level of veterinary care at orangutan rehabilitation centers.

Doctors aggressively treat early heart attacks

An international study involving 467 hospitals in 12 countries found that doctors do a good job of aggressively treating the early stages of heart attacks - even before laboratory tests confirm the diagnosis.

Viragen and University of Miami to advance anti-cancer study

Viragen, Inc. today announced that the Company extended its agreement with the University of Miami and UM/Sylvester Comprehensive Cancer Center to develop a novel form of an immune enhancing drug (IEP 11) that has shown promise in animal studies by inhibiting tumor growth in a broad range of cancers.

Khem Wood, - Dentist in Braggs, OK